# Microvisk Continuous Blood Donation Study

> **NCT06648837** · NA · NOT_YET_RECRUITING · sponsor: **Microvisk Technologies Ltd** · enrollment: 2500 (estimated)

## Conditions studied

- Pulmonary Embolism (Diagnosis)
- Deep Vein Thrombosis
- Atrial Fibrillation (AF)

## Interventions

- **PROCEDURE:** Venepuncture
- **OTHER:** Collection of relevant information

## Key facts

- **NCT ID:** NCT06648837
- **Lead sponsor:** Microvisk Technologies Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-13
- **Primary completion:** 2029-10-30
- **Final completion:** 2029-11-01
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06648837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06648837, "Microvisk Continuous Blood Donation Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06648837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*